Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Piu Medical SpAFRA:IV3 -2.68%14 Debt-to-Equity is 0.41 as of Jun. 2025, which is 2% below its 10-year median of 0.42. GuruFocus rates FRA:IV3 with a GF Score™ of 14/100. The stock has 5 warning signs investors should review. Among 559 Healthcare Providers & Services companies, Piu Medical SpA ranks better than 52.24% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Piu Medical SpA's Debt-to-Equity or its related term are showing as below:
FRA:IV3'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.38 Med: 0.42 Max: 0.49
Current: 0.38
During the past 3 years, the highest Debt-to-Equity Ratio of Piu Medical SpA was 0.49. The lowest was 0.38. And the median was 0.42.
FRA:IV3's Debt-to-Equity is ranked better than 52.24% of 559
companies
in the Healthcare Providers & Services industry
Industry Median: 0.42
vs FRA:IV3: 0.38
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Piu Medical SpA Debt-to-Equity Related Terms
Piu Medical SpA Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Piu Medical SpA's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Piu Medical SpA Debt-to-Equity Chart
Piu Medical SpA Annual Data
Trend
Dec23
Dec24
Dec25
Debt-to-Equity
0.49
0.42
0.38
Piu Medical SpA Semi-Annual Data
Dec23
Dec24
Jun25
Dec25
Debt-to-Equity
0.49
0.42
0.41
0.38
Piu Medical SpA Debt-to-Equity Competitor Comparison
For the Pharmaceutical Retailers subindustry, Piu Medical SpA's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Piu Medical SpA Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Piu Medical SpA's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Piu Medical SpA's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Piu Medical SpA (FRA:IV3) has a Debt-to-Equity of 0.41 as of Jun. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Piu Medical SpA and its competitors. This is near median its historical median of 0.42. Over the past decade, Piu Medical SpA's Debt-to-Equity has ranged from 0.38 to 0.49. According to the industry distribution chart, Piu Medical SpA ranks #267 out of 559 companies in the Healthcare Providers & Services industry, placing it in the top 47.8%.
Is Piu Medical SpA's Debt-to-Equity too high?
Piu Medical SpA's current Debt-to-Equity of 0.41 is near median its 10-year median of 0.42. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 0.49. The Healthcare Providers & Services industry median Debt-to-Equity is 0.42. Piu Medical SpA's value of 0.41 is 2.4% below this industry median. Based on the distribution chart, Piu Medical SpA ranks #267 out of 559 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Piu Medical SpA has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Piu Medical SpA's Debt-to-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Piu Medical SpA ranks #267 out of 559 companies for Debt-to-Equity. This puts Piu Medical SpA in the upper half of its industry. The industry median Debt-to-Equity is 0.42. Piu Medical SpA's value of 0.41 is 2.4% below this benchmark. Historically, Piu Medical SpA's own Debt-to-Equity has ranged from 0.38 to 0.49 over the past decade. While the company's 10-year median is 0.42 vs. the industry median of 0.42, Piu Medical SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 559 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Piu Medical SpA's current Debt-to-Equity of 0.41 is 2.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Piu Medical SpA and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Piu Medical SpA's current Debt-to-Equity is 0.41, which is near median its own 10-year median of 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Piu Medical SpA stock overvalued right now?
Piu Medical SpA (FRA:IV3) has a current Debt-to-Equity of 0.41. The current Debt-to-Equity is 0.41, which is near median its 10-year median of 0.42 and 2.4% below the Healthcare Providers & Services industry median of 0.42. Piu Medical SpA's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Piu Medical SpA (FRA:IV3), the current Debt-to-Equity is 0.41 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Piu Medical SpA specializes in the retail distribution of pharmaceutical and parapharmaceutical products. Its activity includes: sale of prescription drugs; sale of OTC and parapharmaceutical products: OTC medicines, dietary supplements, medical devices, paramedical products, personal care and wellness products, homeopathic medicines, cosmetics, etc.; services: diagnostic testing services, blood parameter analysis and control (glycemia, cholesterol, triglycerides, etc.), rapid testing and screening, nutritional consultation, remote medical assistance and monitoring, telemedicine, etc.
14GF Score
Get the complete analysis for FRA:IV3
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:IV3 has been successfully added to your 
